2388P Split-dose cisplatin plus gemcitabine use and associated clinical outcomes in the first-line (1L) treatment of locally advanced or metastatic urothelial cancer (la/mUC): Results of a retrospective observational study in Germany (CONVINCE)

Autor: Schlack, K., Kubin, T., Ruhnke, M., Schulte, C., Machtens, S., Eisen, A., Osowski, U., Guenther, S., Kearney, M., Lipp, R., Schmitz, S.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S1216-S1216
Databáze: ScienceDirect